All articles tagged with #emma walmsley
GSK's stock rose after CEO Emma Walmsley announced her departure, with Luke Miels set to succeed her. Walmsley's leadership saw strategic shifts including the Haleon demerger and a focus on R&D, leading to a 16% stock increase this year. The company aims for a smooth leadership transition as it prepares for future growth.
GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, as the company aims to accelerate its pipeline and navigate a challenging global environment. The leadership change has been well received by investors, with Miels expected to focus on delivering GSK's growth targets amid geopolitical and market uncertainties.
GSK's CEO Emma Walmsley will step down in December after nine years, with Luke Miels, the company's chief commercial officer, named as her successor to lead the company into its next growth phase and meet future sales targets amid a challenging economic environment.
Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down as CEO of GSK on December 31 after over eight years, with Luke Miels set to succeed her. Despite strategic successes like spinning off Haleon, GSK's share performance has been underwhelming, with only modest growth and a significant decline since Walmsley's appointment.